Re: To Any Expert with knowledge of Clinical Trial Analysis
Thank you for that information. I was wondering if a trial must be based on only ONE endpoint or could they have a trial that have both so that if the PFS did not meet their criteria, they could continue same trial to determine OS. It would allow having the chance of a faster approval but if the endpoint of PFS is not met, there would be no requirement to start another trial for OS.
When the data is released next Monday, would be interested in further comments.
Some of my recent postings have had some humor and discontent involved but actually I am still hoping for some positive news not only for the investors, but also for the patients with ovarian cancer. They need some good news!!